Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, fully integrated pharmaceutical company headquartered in Mumbai, India. It employs over 4,100 people across its global operations and its shares are listed on India’s two large stock exchanges, the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The company’s primary focus is in the areas of inflammation [Asthma/COPD, etc] and metabolic disorders [Diabetes, Obesity, etc]. The Company has branded generic formulation interests in over 95 countries across the world.
Ticker:
GNP
ISIN:
INE935A01035
Address:
Corporate Bldg, Wing (click to copy or hover over here to view full address)
CSRHub includes data on global climate change, CSR, World Council for Sustainable Business Development, environmental pollution, Environment, and Gender.